Top compounds associated with response to AMACR


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.084 0.02
mRNA Erlotinib gCSI pan-cancer AAC -0.14 0.02
mRNA VER-155008 CTRPv2 pan-cancer AAC -0.086 0.02
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.086 0.02
mRNA BMS-195614 CTRPv2 pan-cancer AAC 0.089 0.02
mRNA A-804598 CTRPv2 pan-cancer AAC 0.11 0.02
mRNA tandutinib CTRPv2 pan-cancer AAC 0.084 0.02
mRNA NVP-BEZ235 CTRPv2 pan-cancer AAC 0.097 0.02
mRNA JW-480 CTRPv2 pan-cancer AAC 0.086 0.03
mRNA oligomycin a CTRPv2 pan-cancer AAC 0.081 0.03
Download CSV